Medpace Holdings, Inc.
MEDP
$594.02
$9.111.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.88% | 9.94% | 9.87% | 11.84% | 16.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.88% | 9.94% | 9.87% | 11.84% | 16.24% |
| Cost of Revenue | 5.69% | 4.62% | 4.52% | 6.87% | 10.45% |
| Gross Profit | 17.88% | 12.57% | 12.58% | 14.38% | 19.29% |
| SG&A Expenses | 11.74% | 17.56% | 15.89% | 11.67% | 16.44% |
| Depreciation & Amortization | -0.76% | 3.17% | 6.68% | 11.10% | 13.71% |
| Other Operating Expenses | 16.73% | 5.65% | 4.50% | 6.58% | 17.14% |
| Total Operating Expenses | 11.39% | 6.41% | 5.73% | 7.31% | 14.18% |
| Operating Income | 24.03% | 25.18% | 28.65% | 32.67% | 25.43% |
| Income Before Tax | 20.03% | 24.72% | 32.80% | 41.78% | 35.82% |
| Income Tax Expenses | 28.83% | 34.31% | 30.03% | 35.30% | 47.63% |
| Earnings from Continuing Operations | 18.42% | 23.11% | 33.24% | 42.99% | 33.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.42% | 23.11% | 33.24% | 42.99% | 33.85% |
| EBIT | 24.03% | 25.18% | 28.65% | 32.67% | 25.43% |
| EBITDA | 22.40% | 23.67% | 27.08% | 31.11% | 24.58% |
| EPS Basic | 23.92% | 25.30% | 32.81% | 42.04% | 33.66% |
| Normalized Basic EPS | 26.04% | 27.18% | 32.18% | 40.73% | 35.50% |
| EPS Diluted | 25.23% | 26.54% | 33.55% | 42.24% | 33.86% |
| Normalized Diluted EPS | 27.36% | 28.35% | 32.83% | 41.02% | 35.67% |
| Average Basic Shares Outstanding | -4.47% | -1.79% | 0.52% | 0.76% | 0.19% |
| Average Diluted Shares Outstanding | -5.45% | -2.64% | 0.06% | 0.57% | 0.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |